Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Multi-drug resistant tuberculosis in Finland; treatment outcome and the role of whole genome sequencing

Virve Korhonen, Pia Kivelä, Marjo Haanperä, Hanna Soini, Tuula Vasankari
ERJ Open Research 2022; DOI: 10.1183/23120541.00214-2022
Virve Korhonen
1Department of Respiratory Medicine, Tampere University Hospital, Tampere, Finland
2Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
3Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Virve Korhonen
  • For correspondence: virve.korhonen@tuni.fi
Pia Kivelä
4Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjo Haanperä
2Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Soini
2Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuula Vasankari
5Finnish Lung Health Association (Filha), Helsinki, Finland
6Faculty of Medicine, University of Turku, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tuula Vasankari
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/23120541.00214-2022

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received May 2, 2022
  • Accepted September 21, 2022
  • Published online November 3, 2022.

Article Versions

  • You are currently viewing a previous version of this article (November 3, 2022 - 08:31).
  • View the most recent version of this article
Copyright & Usage 
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Virve Korhonen1,2,3⇑,
  2. Pia Kivelä4,
  3. Marjo Haanperä2,
  4. Hanna Soini2 and
  5. Tuula Vasankari5,6
  1. 1Department of Respiratory Medicine, Tampere University Hospital, Tampere, Finland
  2. 2Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
  3. 3Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
  4. 4Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland
  5. 5Finnish Lung Health Association (Filha), Helsinki, Finland
  6. 6Faculty of Medicine, University of Turku, Turku, Finland
  1. Corresponding author: Virve Korhonen (virve.korhonen{at}tuni.fi)
View Full Text

Article usage

Article usage: November 2022 to December 2022

AbstractFullPdf
Nov 20228322854
Dec 20228202125

Altmetrics

PreviousNext
Back to top
Vol 9 Issue 1 Table of Contents
ERJ Open Research: 9 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multi-drug resistant tuberculosis in Finland; treatment outcome and the role of whole genome sequencing
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Multi-drug resistant tuberculosis in Finland; treatment outcome and the role of whole genome sequencing
Virve Korhonen, Pia Kivelä, Marjo Haanperä, Hanna Soini, Tuula Vasankari
ERJ Open Research Jan 2022, 00214-2022; DOI: 10.1183/23120541.00214-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Multi-drug resistant tuberculosis in Finland; treatment outcome and the role of whole genome sequencing
Virve Korhonen, Pia Kivelä, Marjo Haanperä, Hanna Soini, Tuula Vasankari
ERJ Open Research Jan 2022, 00214-2022; DOI: 10.1183/23120541.00214-2022
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Adding a biologic to allergen immunotherapy increases treatment efficacy
  • Modifiable lifestyle risk factors for sarcoidosis: a nested case-control study
  • EBUS-guided transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: safety, feasibility and diagnostic yield – experience in 50 cases
Show more Original research article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society